Tuesday, June 29, 2021

Role of the Prognostic Nutritional Index in Patients With Soft-tissue Sarcoma

xlomafota13 shared this article with you from Inoreader

In Vivo. 2021 Jul-Aug;35(4):2349-2355. doi: 10.21873/invivo.12511.

ABSTRACT

BACKGROUND: This study aimed to determine whether the prognostic nutritional index (PNI) can predict the prognosis in patients with soft-tissue sarcoma (STS) before treatment and to examine whether there is an association between PNI values and clinical characteristics.

PATIENTS AND METHODS: The data on 100 patients with primary STS were retrospectively reviewed. The cohort included 55 men and 45 women, with a mean age of 64 years. The mean follow-up duration was 41.7 months.

RESULTS: The median PNI was 51.35. The PNI was significantly inversely associated with tumor size, tumor grade, and age. We found that the PNI was a significant prognostic marker for disease-specific and event-free survival using univariate and multivariate analyses. Patients with a low PNI had poorer disease-specific and event-free survival than those with a high PNI.

CO NCLUSION: These results suggest that the PNI can be used as a prognostic marker in patients with STS.

PMID:34182517 | DOI:10.21873/invivo.12511

View on the web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...